title: Effects of free fatty acids on hepatic glycogenolysis and gluconeogenesis in conscious dogs.
abstract: The aim of this study was to determine the effect of high levels of free fatty acids (FFA) and/or hyperglycemia on hepatic glycogenolysis and gluconeogenesis. Intralipid was infused peripherally in 18-h-fasted conscious dogs maintained on a pancreatic clamp in the presence (FFA + HG) or absence (FFA + EuG) of hyperglycemia. In the control studies, Intralipid was not infused, and euglycemia (EuG) or hyperglycemia (HG) was maintained. Insulin and glucagon were clamped at basal levels in all four groups. The arterial blood glucose level increased by 50% in the HG and FFA + HG groups. It did not change in the EuG and FFA + EuG groups. Arterial plasma FFA increased by approximately 140% in the FFA + EuG and FFA + HG groups but did not change significantly either in the EuG or HG groups. Arterial glycerol levels increased by approximately 150% in both groups. Overall (3-h) net hepatic glycogenolysis was 196 +/- 26 mg/kg in the EuG group. It decreased by 96 +/- 20, 82 +/- 16, and 177 +/- 22 mg/kg in the HG, FFA + EuG, and FFA + HG groups, respectively. Overall (3-h) hepatic gluconeogenic flux was 128 +/- 22 mg/kg in the EuG group, but it was suppressed by 30 +/- 9 mg/kg in response to hyperglycemia. It was increased by 59 +/- 12 and 56 +/- 10 mg/kg in the FFA + EuG and FFA + HG groups, respectively. In conclusion, an increase in plasma FFA and glycerol significantly inhibited hepatic glycogenolysis and markedly stimulated hepatic gluconeogenesis.
authors.affiliation: Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0615, USA.
authors.forename: Chang An
authors.initials: CA
authors.lastname: Chu
authors.forename: Stephanie M
authors.initials: SM
authors.lastname: Sherck
authors.forename: Kayano
authors.initials: K
authors.lastname: Igawa
authors.forename: Dana K
authors.initials: DK
authors.lastname: Sindelar
authors.forename: Doss W
authors.initials: DW
authors.lastname: Neal
authors.forename: Maya
authors.initials: M
authors.lastname: Emshwiller
authors.forename: Alan D
authors.initials: AD
authors.lastname: Cherrington
mesh_terms: D020155:3-Hydroxybutyric Acid / Q000097:blood / Q000378:metabolism; D000596:Amino Acids / Q000097:blood / Q000378:metabolism; D000818:Animals; D001158:Arteries; D001786:Blood Glucose / Q000378:metabolism; D004285:Dogs; D005230:Fatty Acids, Nonesterified / Q000097:blood / Q000378:metabolism / Q000494:pharmacology*; D005260:Female; D005943:Gluconeogenesis / Q000187:drug effects*; D005947:Glucose / Q000378:metabolism; D005990:Glycerol / Q000097:blood / Q000378:metabolism; D006003:Glycogen / Q000378:metabolism*; D007700:Kinetics; D008099:Liver / Q000378:metabolism*; D008297:Male
chemical_list: D000596:Amino Acids; D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D006003:Glycogen; D005947:Glucose; D005990:Glycerol; D020155:3-Hydroxybutyric Acid